Clinical trials
Phase 2 Lymphoma, T-Cell, Peripheral trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 2 |
| 2011 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 6 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ruijin Hospital | 3 |
| Auxilio Mutuo Cancer Center | 2 |
| Fudan University | 2 |
| Sun Yat-sen University | 2 |
| CerRx, Inc. | 1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 1 |
| Chinese Academy of Medical Sciences | 1 |
| Czech Lymphoma Study Group | 1 |
| Genor Biopharma Co., Ltd. | 1 |
| Guangdong Provincial People's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Peripheral | 28 |
| Lymphoma, Large B-Cell, Diffuse | 3 |
| Recurrence | 3 |
| Burkitt Lymphoma | 2 |
| Lymphoma | 2 |
| Lymphoma, Follicular | 2 |
| Lymphoma, Mantle-Cell | 2 |
| Lymphoma, T-Cell | 2 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Hodgkin Disease | 1 |
Trials
Showing 1 to 25 of 28. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.